Background: Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNA) is the preferred method for biopsying the gastrointestinal tract, and rapid on-site cytological evaluation is considered standard practice. Our institution does not perform on-site evaluation; this study analyzes our overall diagnostic yield, accuracy, and incidence of nondiagnostic cases to determine the validity of this strategy. Design: Data encompassing clinical information, procedural records, and cytological assessment were analyzed for gastrointestinal EUS-FNA procedures (n = 85) performed at Vancouver General Hospital from January 2012 to January 2013. We compared our results with those of studies that had on-site evaluation and studies that did not have on-site evaluation. Results: Eighty-five biopsies were performed in 78 patients, from sites that included the pancreas, the stomach, the duodenum, lymph nodes, and retroperitoneal masses. Malignancies were diagnosed in 45 (53%) biopsies, while 24 (29%) encompassed benign entities. Suspicious and atypical results were recorded in 8 (9%) and 6 (7%) cases, respectively. Only 2 (2%) cases received a cytological diagnosis of ‘nondiagnostic'. Our overall accuracy was 72%, our diagnostic yield was 98%, and our nondiagnostic rate was 2%. Our results did not significantly differ from those of studies that did have on-site evaluation. Conclusion: Our study highlights that adequate diagnostic accuracy can be achieved without on-site evaluation.

Klapman JB, Logrono R, Dye CE, Waxman I: Clinical impact of on-site cytopathology interpretation on endoscopic ultrasound-guided fine needle aspiration. Am J Gastroenterol 2003;98:1289-1294.
Bellizi AM, Stewlow EB: Pancreatic cytopathology. Arch Pathol Lab Med 2009;133:388-404.
Ylagen LR, Edmundowicz S, Kasal K, Walsh D, Lu DW: Endoscopic ultrasound fine-needle aspiration cytology of pancreatic carcinoma: a 3-year experience and review of the literature. Cancer Cytopathol 2002;96:362-369.
Turner BG, Cizginer S, Agarwal D, Yang J, Bishop Pitman M, Brugge WR: Diagnosis of pancreatic neoplasia with EUS and FNA: a report of accuracy. Gastrointest Endosc 2010;71:91-98.
Eloubeidi MA, Jhala D, Chhieng DC, et al: Yield of endoscopic ultrasound guided fine needle aspiration biopsy in patients with suspected pancreatic carcinoma. Cancer Cytopathol 2003;99:285-292.
Leiman G: My approach to pancreatic fine needle aspiration. J Clin Pathol 2007;60:43-49.
Storch I, Jorda M, Thurer R: Advantage of EUS Trucut biopsy combined with fine-needle aspiration without immediate on-site cytopathologic examination. Gastrointest Endosc 2006;64:505-511.
Schmidt RL, Witt BL, Matynia AP, Barraza G, Layfield LJ, Adler DG: Rapid on-site evaluation increases endoscopic ultrasound-guided fine-needle aspiration adequacy for pancreatic lesions. Dig Dis Sci 2013;58:872-882.
Nguyen YP, Maple JT, Zhang Q, et al: Reliability of gross visual assessment of specimen adequacy during EUS-guided FNA of pancreatic masses. Gastrointest Endosc 2009;69:1264-1270.
Iglesias-Garcia J, Dominguez-Munoz JE, Abdulkader I, et al: Influence of on-site cytopathology evaluation on the diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) of solid pancreatic masses. Am J Gastroenterol 2011;106:1705-1710.
Kim J, Ryu JK, Park JM, et al: Clinical factors associated with accuracy of EUS-FNA for pancreatic or peripancreatic solid mass without on-site cytopathologists. J Gastroenterol Hepatol 2014;29:887-892.
Afify AM, al-Khafaji BM, Kim B, Scheiman JM: Endoscopic ultrasound - guided fine needle aspiration of the pancreas: diagnostic utility and accuracy. Acta Cytol 2003;47:341-348.
Raut CP, Grau AM, Staerkel GA, et al: Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer. J Gastrointest Surg 2003;7:118-126.
Volmar KE, Vollmer RT, Jowell PS, Nelson RC, Xie HB: Pancreatic FNA in 1,000 cases: a comparison of imaging modalities. Gastrointest Endosc 2005;61:854-861.
Wilson JL, Kalade A, Prasad S, et al: Diagnosis of solid pancreatic masses by endoscopic ultrasound-guided fine-needle aspiration. Intern Med J 2009;39:32-37.
Hewitt MJ, McPhail MJ, Possamai L, Dhar A, Vlavianos P, Monohan KJ: EUS- guided FNA for diagnosis of solid pancreatic neoplasms: a meta analysis. Gastrointest Endosc 2012;75:319-331.
Jhala NC, Jhala DN, Chhieng DC, Eloubeidi MA, Eltoum IA: Endoscopic ultrasound-guided fine needle aspiration: a cytopathologist's perspective. Am J Clin Pathol 2003;120:351-367.
Itoi T, Tsuchiya T, Itokawa F, et al: Histological diagnosis by EUS-guided fine-needle aspiration biopsy in pancreatic solid masses without on-site cytopathologist: a single center experience. Dig Endosc 2011;23:34-38.
Cermak TS, Wang B, De Brito P, Carroll J, Haddad N, Sidawy MK: Does on-site adequacy evaluation reduce the non-diagnostic rate in endoscopic ultrasound-guided fine-needle aspiration of pancreatic lesions? Cancer Cytopathol 2012;120:319-325.
LeBlanc JK, Ciaccia D, Al-Assi MT, et al: Optimal number of EUS-guided fine needle passes needed to obtain a correct diagnosis. Gastrointest Endosc 2004;59:475-481.
Erickson RA, Sayage-Rabie L, Beissner RS: Factors predicting the number of EUS-guided fine-needle passes for diagnosis of pancreatic malignancies. Gastrointest Endosc 2000;51:184-190.
Chhieng DC, Jhala D, Jhala N, et al: Endoscopic ultrasound-guided fine-needle aspiration biopsy: a study of 103 cases. Cancer Cytopathol 2002;96:232-239.
Shin HJC, Lahoti S, Sneige N: Endoscopic ultrasound-guided fine-needle aspiration in 179 cases. Cancer Cytopathol 2002;96:174-180.
Hayashi T, Ishiwatari H, Yoshida M, et al: Rapid on-site evaluation by endosonographer during endoscopic ultrasound-guided fine needle aspiration for pancreatic solid masses. J Gastroenterol Hepatol 2013;28:656-663.
Hikichi T, Irisawa A, Bhutani MS, et al: Endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic masses with rapid on-site cytological evaluation by endosonographers without attendance of cytopathologists. J Gastroenterol 2009;44:322-328.
de Luna R, Eloubeidi MA, Sheffield MV, et al: Comparison of ThinPrep and conventional preparations in pancreatic fine-needle aspiration biopsy. Diagn Cytopathol 2004;30:71-76.
Michael CW, Hunter B: Interpretation of fine-needle aspirates processed by the ThinPrep technique: cytologic artifacts and diagnostic pitfalls. Diagn Cytopathol 2000;23:6-13.
Belsley NA, Pitman MB, Lauwers GY, Brugge WR, Deshpande V: Serous cystadenoma of the pancreas: limitations and pitfalls of endoscopic ultrasound-guided fine-needle aspiration biopsy. Cancer Cytopathol 2008;114:102-110.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.